TSPO and stroke disorder: In the same line, Fujinaga et al. used a stroke model in rats to test and select new TSPO tracer candidates and identified that amongst those 2-(5-(6-[18F]fluoropyridin-3-yl)-2-oxobenzo[d]oxazol-3(2H)-yl)-N-methyl-N-phenylacetamide (compound d in [74]) and [18F]5 (N-(4-[18F]fluorobenzyl)-N-methyl-2-(7-methyl-8-oxo-2-phenyl-7,8-dihydro-9H-purin-9-yl)acetamide) [75] were the best candidates with better signal-to-noise ratio than [11C]-R-PK11195.